Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
作者信息
Varma A, Saliba R M, Torres H A, Afrough A, Hosing C, Khouri I F, Nieto Y, Shah N D, Parmar S, Bashir Q, Ahmed S, Jones R B, Kebriaei P, Olson A L, Shpall E J, Alousi A M, Qazilbash M H, Champlin R E, Popat U
机构信息
Department of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
Bone Marrow Transplant. 2016 Jul;51(7):999-1001. doi: 10.1038/bmt.2016.28. Epub 2016 Mar 7.
Abstract
摘要
相似文献
1
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
Bone Marrow Transplant. 2016 Jul;51(7):999-1001. doi: 10.1038/bmt.2016.28. Epub 2016 Mar 7.
2
Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.
Biol Blood Marrow Transplant. 2016 Apr;22(4):717-722. doi: 10.1016/j.bbmt.2015.12.010. Epub 2015 Dec 19.
3
The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
Front Immunol. 2018 Sep 20;9:2153. doi: 10.3389/fimmu.2018.02153. eCollection 2018.
4
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.
Ann Hematol. 2020 Dec;99(12):2893-2901. doi: 10.1007/s00277-020-04112-4. Epub 2020 Jun 22.
5
Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents.
Bone Marrow Transplant. 2022 May;57(5):846-848. doi: 10.1038/s41409-022-01640-7. Epub 2022 Mar 24.
6
Collection, cryopreservation and autologous transplantation with circulating hemopoietic stem cells in patients with multiple myeloma and lymphoma.
Bone Marrow Transplant. 1990 Jan;5 Suppl 1:33-4.
7
Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).
Br J Haematol. 2019 Sep;186(6):e170-e175. doi: 10.1111/bjh.16050. Epub 2019 Jun 17.
8
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan.
Blood Cancer J. 2017 Nov 23;7(12):631. doi: 10.1038/s41408-017-0002-2.
9
Adequate Engraftment With Lower Hematopoietic Stem Cell Dose.
Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):260-263. doi: 10.1016/j.clml.2019.12.018. Epub 2020 Jan 8.
10
Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.
Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):409-415.e1. doi: 10.1016/j.clml.2015.02.024. Epub 2015 Mar 5.
引用本文的文献
1
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy.
J Clin Transl Hepatol. 2016 Sep 28;4(3):206-227. doi: 10.14218/JCTH.2016.00017. Epub 2016 Aug 10.
2
How I treat hepatitis C virus infection in patients with hematologic malignancies.
Blood. 2016 Sep 15;128(11):1449-57. doi: 10.1182/blood-2016-05-718643. Epub 2016 Jul 21.
本文引用的文献
1
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
Biol Blood Marrow Transplant. 2013 Mar;19(3):410-7. doi: 10.1016/j.bbmt.2012.10.029. Epub 2012 Nov 2.
2
Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.
J Hepatol. 2012 Dec;57(6):1177-85. doi: 10.1016/j.jhep.2012.07.031. Epub 2012 Aug 4.
3
High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies.
Ann Hematol. 2011 Feb;90(2):159-64. doi: 10.1007/s00277-010-1055-5. Epub 2010 Sep 7.
4
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
J Clin Oncol. 2010 Sep 20;28(27):4184-90. doi: 10.1200/JCO.2010.28.1618. Epub 2010 Jul 26.
5
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Haematologica. 2009 Feb;94(2):249-57. doi: 10.3324/haematol.13756. Epub 2009 Jan 14.
6
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
J Clin Oncol. 2005 Apr 1;23(10):2240-7. doi: 10.1200/JCO.2005.08.012.
7
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.
N Engl J Med. 2003 May 8;348(19):1875-83. doi: 10.1056/NEJMoa022340.
8
Causes and risk factors for liver injury following bone marrow transplantation.
J Clin Gastroenterol. 2003 May-Jun;36(5):421-6. doi: 10.1097/00004836-200305000-00013.
9
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
Bone Marrow Transplant. 2003 Feb;31(4):295-300. doi: 10.1038/sj.bmt.1703826.
10
Introduction to therapy of hepatitis C.
Hepatology. 2002 Nov;36(5 Suppl 1):S114-20. doi: 10.1053/jhep.2002.36226.
Zotero 插件